NorthWest Biotherapeutics Inc (NWBO)

[trocprofit]

I believe a valuation of 3-5 billion on positive top line results is reasonable given historical valuations of similar biotechs. I would expect a higher valuation on a buyout. In the meantime I am of the camp that believes August is data gathering of 36 month post enrollment combined with 2018 spring refresh and will bring topline and lock announcement within the next two weeks. Then November will bring full release of unblinded data. That said, stock and warrants combined, I would expect a $2 billion valuation on initial positive release, or about $2.50 per share.